Rice William G. 4
4 · Aptose Biosciences Inc. · Filed Jan 23, 2023
Insider Transaction Report
Form 4
Rice William G.
DirectorChair, President & CEO
Transactions
- Award
Common Shares
2023-01-19+150,000→ 513,252 total - Award
Employee Stock Option (Right to Buy)
2023-01-19+400,000→ 400,000 totalExercise: $0.66Exp: 2033-01-19→ Common Shares (400,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the options vest on January 19, 2024; the remaining fifty percent (50%) vest as follows: One-third (1/3) on January 19, 2025; one-third on (1/3) on January 19, 2026; and one-third (1/3) on January 19, 2027.